Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Kian Santang Muliatama Tbk. (RGAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp189 (market cap 277.25B, 7.9M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Kian Santang Muliatama Tbk. is more actively traded (7.9M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | RGAS | |
|---|---|---|
Market Cap | 319B | 277.25B |
Volume | 124.3K | 7.9M |
Lot | 1.24K | 79K |
Turnover | 28.28M | 1.5B |
Average Price | 227.48 | 189.43 |
Value | 28.28M | 1.5B |
Indicative Equilibrium Price | 228 | 189 |
Indicative Equilibrium Volume | 100 | 13.98K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →
